LINNAEUS THERAPEUTICS

linnaeus-therapeutics-logo

Linnaeus Therapeutics is a development stage biotech company engaged in the identification and development of small molecule agents that modulate cellular differentiation for the treatment of cancer and disorders of pigmentation.Linnaeus is a Penn Center for Innovation UPstart company that was founded in 2016 and is based upon discoveries from the Ridky lab at the University of Pennsylvania.

#SimilarOrganizations #People #Financial #Website #More

LINNAEUS THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical Therapeutics

Founded:
2016-01-01

Address:
Haddonfield, New Jersey, United States

Country:
United States

Website Url:
http://www.linnaeustx.com

Total Employee:
1+

Status:
Active

Contact:
856-433-1300

Email Addresses:
[email protected]

Total Funding:
20.74 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Wordpress Plugins Nginx Sitelinks Search Box Microsoft Exchange Online


Similar Organizations

rakuten-medical-logo

Rakuten Medical

Rakuten Medical is a Bio-technology Company.

remix-therapeutics-logo

Remix Therapeutics

Remix Therapeutics is a biotechnology company.


Current Advisors List

nikos-iatropoulos_image

Nikos Iatropoulos Board Member @ Linnaeus Therapeutics
Board_member
2018-01-01

Current Employees Featured

todd-ridky_image

Todd Ridky
Todd Ridky Co-founder @ Linnaeus Therapeutics
Co-founder

patrick-mooney_image

Patrick Mooney
Patrick Mooney CEO @ Linnaeus Therapeutics
CEO
2016-06-01

christopher-natale_image

Christopher Natale
Christopher Natale Co-Founder & VP of Research @ Linnaeus Therapeutics
Co-Founder & VP of Research
2020-02-01

Founder


christopher-natale_image

Christopher Natale

todd-ridky_image

Todd Ridky

Investors List

penn-medicine-co-investment-fund_image

Penn Medicine Co-Investment Program

Penn Medicine Co-Investment Program investment in Series B - Linnaeus Therapeutics

kairos-venture-investments-llc_image

Kairos Ventures

Kairos Ventures investment in Series B - Linnaeus Therapeutics

kairos-venture-investments-llc_image

Kairos Ventures

Kairos Ventures investment in Series A - Linnaeus Therapeutics

penn-medicine-co-investment-fund_image

Penn Medicine Co-Investment Program

Penn Medicine Co-Investment Program investment in Series A - Linnaeus Therapeutics

Official Site Inspections

http://www.linnaeustx.com Semrush global rank: 3.29 M Semrush visits lastest month: 4.96 K

  • Host name: 50.211.202.35.bc.googleusercontent.com
  • IP address: 35.202.211.50
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Linnaeus Therapeutics"

Home - Linnaeus

Linnaeus is a Penn Center for Innovation UPstart company that was founded in 2016 and is based upon discoveries from the Ridky lab at the University of Pennsylvania. We are …See details»

About - Linnaeus

Linnaeus is a Penn Center for Innovation UPstart company that was founded in 2016. Linnaeus is based upon discoveries from the Ridky lab at the University of Pennsylvania. We focus on …See details»

Team - Linnaeus

We have assembled a management and development team with complementary skill sets and differing areas of domain expertise that should allow us to get our drug-candidates into …See details»

Linnaeus Therapeutics - Crunchbase Company Profile …

Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.See details»

Linnaeus Therapeutics, Inc. | LinkedIn

Linnaeus Therapeutics, Inc. is a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics that...See details»

Company Information - RocketReach

Https://linnaeustx.com/ Employees: 5 (5 on RocketReach) Founded: 2016: Address: 30 Washington Ave Suite F, Haddonfield, New Jersey 08033, US Phone (856) 433-1500: …See details»

Linnaeus Therapeutics | Life Sciences PA

Www.linnaeustx.com About Linnaeus Therapeutics is a development stage biotech company engaged in the identification and development of small molecule agents for the treatment of …See details»

Linnaeus – Funding, Valuation, Investors, News

Year Founded: 2016 Key Executives: • Patrick Mooney, MD CEO • Tina Garyantes, PhD, SVP R&D • Chris Natale, PhD Founder and Director of Research Location: Philadelphia, PA …See details»

Linnaeus Therapeutics - Craft

See insights on Linnaeus Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Linnaeus Therapeutics - Overview, News & Similar companies

Linnaeus Therapeutics contact info: Phone number: (856) 433-1300 Website: www.linnaeustx.com What does Linnaeus Therapeutics do? Linnaeus Therapeutics, Inc. is a …See details»

Linnaeus Therapeutics Granted Orphan Drug …

Linnaeus Therapeutics, Inc. is a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small-molecule oncology therapeutics that target G protein-coupled receptors.See details»

Linnaeus Therapeutics - VentureRadar

Website: https://linnaeustx.com/ Develops G protein-coupled estrogen receptor (GPER) agonists for cancer treatments and modulates melanocyte pigmentation for skin pigmentation correction …See details»

Patrick Mooney - Chief Executive Officer at Linnaeus ... - ZoomInfo

Who is Linnaeus Therapeutics’s Chief Executive Officer? Get the details of Patrick Mooney's business profile including email address, phone number, work history and more.See details»

linnaeustx.com Reviews: Is this site a scam or legit?

We determined this score by aggregating 53 powerful factors to expose high-risk activity and see if linnaeustx.com is safe. Our in-depth review examines the website and its REAL ESTATE …See details»

Contact - Linnaeus

If you’d like more information about our company, we’d love to hear from you. Please fill out the form below, and someone from our team will be in touch with you.See details»

Linnaeus Therapeutics | CipherBio

Explore Linnaeus Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»

Linnaeus Therapeutics Announces Presentation of LNS8801 …

LNS8801 is an orally bioavailable and highly specific and potent agonist of GPER whose activity is dependent on the expression of GPER. GPER activation by LNS8801 rapidly and durably …See details»

Linnaeus Therapeutics-动脉网 - vbdata.cn

Linnaeus是宾夕法尼亚州创新UPstart公司,成立于2016年.Linnaeus基于宾夕法尼亚大学Ridky实验室的发现。See details»

News - Linnaeus

Linnaeus Therapeutics Announces Presentation of LNS8801 Clinical Data at 2022 ESMO Annual Meeting Haddonfield NJ, September 12, 2022 - Linnaeus Therapeutics, Inc. (Linnaeus), a …See details»

linkstock.net © 2022. All rights reserved